Related Experiment Video
Updated: Jul 12, 2026

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Maintenance of myocyte volume homeostasis during stress by diazoxide is cardioprotective
Ashraf S Al-Dadah1, Rochus K Voeller, Richard B Schuessler
1Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Insights
Diazoxide effectively prevents myocyte swelling and preserves contractility during metabolic inhibition, independent of ATP-sensitive potassium channels. This suggests a novel mechanism for protecting heart cells from stunning.
Area of Science:
- Cardiology
- Cell Physiology
- Biochemistry
Background:
- Myocyte swelling and reduced contractility occur during hyperkalemic cardioplegia and hyposmotic stress.
- Diazoxide, an adenosine triphosphate-sensitive potassium channel (K(ATP)) opener, previously attenuated these effects.
- The current study investigates diazoxide's impact on metabolic inhibition-induced myocyte changes and explores underlying mechanisms.
Purpose of the Study:
- To determine the effect of diazoxide on myocyte swelling and contractility following metabolic inhibition.
- To elucidate the potential mechanisms by which diazoxide exerts its protective effects.
Main Methods:
- Isolated rabbit myocytes were subjected to metabolic inhibition (using sodium cyanide and 2-deoxyglucose) with or without diazoxide.
- Specific adenosine triphosphate-sensitive potassium (K(ATP)) channel blockers (HMR1098 and 5-hydroxydeconoate) were used to investigate the role of sarcolemmal and mitochondrial K(ATP) channels.
- Myocyte volume and contractility were measured before, during, and after the intervention.
Main Results:
- Metabolic inhibition led to significant myocyte swelling and decreased contractility.
- Diazoxide completely prevented myocyte swelling and attenuated the reduction in contractility.
- The protective effects of diazoxide were observed irrespective of the presence of K(ATP) channel blockers.
Conclusions:
- Diazoxide attenuates myocyte swelling and preserves contractility during metabolic inhibition, independent of K(ATP) channels.
- These findings suggest a K(ATP)-independent role for diazoxide in maintaining myocyte volume homeostasis.
- Preventing myocyte swelling improves contractility, supporting the hypothesis that swelling contributes to myocardial stunning.
Background:
We previously demonstrated that myocyte swelling and reduced contractility secondary to hyperkalemic cardioplegia and hyposmotic stress are attenuated by the addition of diazoxide, an adenosine triphosphate-sensitive potassium channel (K(ATP)) opener. The goal of this study was to investigate the effect of diazoxide on myocyte swelling and reduced contractility after metabolic inhibition and to attempt to summarize the potential mechanisms involved.
Methods:
Isolated rabbit myocytes were perfused with Tyrode's control solution for 20 minutes, followed by test solution for 20 minutes. Test solutions included (1) Tyrode's control, (2) a metabolic inhibition solution containing sodium cyanide and 2-deoxyglucose, (3) metabolic inhibition plus diazoxide, (4) metabolic inhibition plus diazoxide plus HMR1098 (a sarcolemmal K(ATP)-channel blocker), or (5) metabolic inhibition plus diazoxide plus 5-hydroxydeconoate (a mitochondrial K(ATP)-channel blocker). Myocytes were then reexposed to Tyrode's solution for 20 minutes. Volume measurements were taken every 5 minutes. Contractility was recorded using edge-detection software at baseline and at 10 and 20 minutes of reexposure to Tyrode's solution.
Results:
Simulated ischemia (metabolic inhibition) caused significant myocyte swelling and associated reduced contractility. The addition of diazoxide abolished myocyte swelling and attenuated the associated reduced contractility. Observations with diazoxide were unchanged by the addition of HMR 1098 or 5-hydroxydeconoate.
Conclusions:
Diazoxide, with or without either K(ATP)-channel blocker, attenuated the significant myocyte swelling and reduced contractility secondary to metabolic inhibition. These data suggest a role for diazoxide, independent of the K(ATP) channel, in myocyte volume homeostasis. In addition, the prevention of myocyte swelling resulted in improved contractility, consistent with previous data and the hypothesis that myocyte swelling may participate in the phenomenon of myocardial stunning.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure II: Pathophysiology
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inotropic Agents
Pathophysiology of Cardiac Performance
